Pyronaridine
(Redirected from Pyronaridine tetraphosphate)
Pyronaridine[edit | edit source]
Pyronaridine is an antimalarial drug used in the treatment of malaria, a disease caused by Plasmodium parasites. It is particularly effective against the Plasmodium falciparum and Plasmodium vivax species. Pyronaridine is often used in combination with other antimalarial agents to enhance efficacy and reduce the risk of resistance.
History[edit | edit source]
Pyronaridine was first synthesized in the 1970s in China. It was developed as part of efforts to find new treatments for malaria, which was a significant public health issue in many parts of the world. The drug was initially used in China and later introduced to other countries where malaria is endemic.
Mechanism of Action[edit | edit source]
Pyronaridine works by interfering with the parasite's ability to detoxify heme, a byproduct of hemoglobin digestion. The accumulation of toxic heme within the parasite leads to its death. This mechanism is similar to that of other antimalarial drugs such as chloroquine.
Pharmacokinetics[edit | edit source]
Pyronaridine is administered orally and is well absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted primarily in the urine. The drug has a long half-life, which allows for once-daily dosing in combination therapies.
Clinical Use[edit | edit source]
Pyronaridine is used in combination with artesunate, another antimalarial drug, in a fixed-dose combination known as pyronaridine-artesunate. This combination is effective against both uncomplicated and severe malaria. The combination therapy is preferred because it reduces the likelihood of resistance development and provides a synergistic effect against the malaria parasite.
Side Effects[edit | edit source]
Common side effects of pyronaridine include headache, dizziness, and gastrointestinal disturbances such as nausea and vomiting. In rare cases, it may cause liver enzyme elevations, which necessitates monitoring in patients with pre-existing liver conditions.
Resistance[edit | edit source]
Resistance to pyronaridine is relatively rare, but as with all antimalarial drugs, there is a risk of resistance developing over time. The use of combination therapies helps to mitigate this risk by attacking the parasite through multiple mechanisms.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD